
- /
- Supported exchanges
- / XETRA
- / EUZ.XETRA
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ XETRA) stock market data APIs
Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Data Overview
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eckert & Ziegler Strahlen- und Medizintechnik AG (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Eckert & Ziegler Strahlen- und Medizintechnik AG data using free add-ons & libraries
Get Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental Data
Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental data includes:
- Net Revenue: 299 M
- EBITDA: 81 700 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Eckert & Ziegler Strahlen- und Medizintechnik AG Earnings data
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: NaN
Get Eckert & Ziegler Strahlen- und Medizintechnik AG End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eckert & Ziegler Strahlen- und Medizintechnik AG News

Eckert & Ziegler (ETR:EUZ) jumps 5.3% this week, though earnings growth is still tracking behind three-year shareholder returns
It hasn't been the best quarter for Eckert & Ziegler SE (ETR:EUZ) shareholders, since the share price has fallen 22% in that time. But at least the stock is up over the last three years. Arguably you'...


Brachytherapy Devices Market Growth Opportunities and Competitive Intelligence (2025-2030) Featuring Varian Medical Systems, Elekta, Ion Beam Applications, C. R. Bard, and Eckert & Ziegler Among Others
Company Logo Key market opportunities in the brachytherapy devices sector include precision imaging and digital treatment planning advancements, innovative isotope technologies, and strategic manufac...

Oeneo And 2 Other Undiscovered Gems With Strong Potential
As European markets experience a positive shift, buoyed by hopes of lower U.S. borrowing costs and rising business activity, investors are increasingly looking towards small-cap stocks for opportuniti...

Eckert & Ziegler Second Quarter 2025 Earnings: EPS: €0.19 (vs €0.17 in 2Q 2024)
Eckert & Ziegler (ETR:EUZ) Second Quarter 2025 Results Key Financial Results Revenue: €80.6m (up 3.7% from 2Q 2024). Net income: €11.7m (up 7.5% from 2Q 2024). Profit margin: 14% (in line with 2...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.